PRQR
ProQR Therapeutics BV
NASDAQ: PRQR · HEALTHCARE · BIOTECHNOLOGY
$1.57
+1.95% today
Updated 2026-04-30
Market cap
$155.93M
P/E ratio
—
P/S ratio
9.54x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
ProQR Therapeutics BV (PRQR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $-2.33M | $-14.46M | $-24.23M | $-34.22M | $-34.95M | $-30.68M | $-43.97M | $-47.06M | $-26.01M | $-68.51M | $21.55M | $-36.39M | $-50.71M |
| Capital expenditures | $0.00 | $137000.00 | $1.23M | $1.32M | $2.54M | $121000.00 | $312000.00 | $580000.00 | $924000.00 | $484000.00 | $708000.00 | $1.37M | $1.42M | $979745.00 |
| Depreciation | — | $24000.00 | $126000.00 | $480000.00 | $1.25M | $1.06M | $992000.00 | $2.05M | $2.35M | $2.33M | $2.52M | $2.51M | $2.76M | — |
| Stock-based comp | — | $41000.00 | $646000.00 | $1.21M | $2.45M | $4.02M | $3.22M | $9.11M | $7.84M | $6.22M | $2.87M | $3.11M | $2.54M | $4.01M |
| Free cash flow | — | $-2.47M | $-15.69M | $-25.56M | $-36.76M | $-35.07M | $-30.99M | $-44.55M | $-47.98M | $-26.50M | $-69.22M | $20.18M | $-37.81M | $-51.69M |
| Investing cash flow | — | $-137000.00 | $-1.23M | $-1.32M | $-2.54M | $-121000.00 | $-312000.00 | $-580000.00 | $-924000.00 | $-425000.00 | $-702000.00 | $4.28M | $-4.07M | — |
| Financing cash flow | $808000.00 | $6.35M | $119.88M | $1.62M | $357000.00 | $26.64M | $88.65M | $50.20M | $14.50M | $136.83M | $-30.89M | $-2.27M | $70.28M | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |